As artificial intelligence (AI) permeates the regulatory world, experts said it won't take over regulatory professionals' ...
More than 500 comments have been submitted in response to the US Food and Drug Administration’s (FDA) discussion paper on ...
Navigating Europe’s complex environmental and sustainability legislation can be daunting, but healthcare product ...
A top US Food and Drug Administration (FDA) enforcement official announced that the agency conducted more unannounced drug ...
Sponsored Content] Health Canada’s 14 September 2026 interim policy introduces flexibility in ethics reporting, investigator ...
Patients who reviewed and signed a patient agreement form (PAF) for mifepristone and misoprostol under the US Food and Drug ...
The Hong Kong Department of Health has unveiled the timetable for launching its Centre for Medical Products Regulation (CMPR) and starting to approve medical products directly. In 2023, government ...
Regulatory Recon is our regular intelligence briefing for the regulatory affairs space, bringing you the top regulatory, ...
Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.
The US Food and Drug Administration (FDA) on Tuesday issued draft guidance laying out its proposed regulatory approach to ...
The US Food and Drug Administration (FDA) issued revised draft guidance on Thursday aimed at assisting sponsors of ...
Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug and medical ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results